Event Brief
UPDATED Apr 13, 2026 at 9:00 AM ET
Apr 10, 2026 at 2:00 PM ET
Revolution Medicines' pancreatic cancer drug trial succeeds
By The BriefBrief
Revolution Medicines' drug for pancreatic cancer succeeded in a Phase 3 trial.
WHO: Revolution Medicines
WHAT: drug for pancreatic cancer succeeded in a Phase 3 trial
WHEN: Apr 13, 2026 at 8:04 AM ET
WHERE: USA
WHY: The trial was highly anticipated and aimed at treating pancreatic cancer.
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
Amazon faces months of repairs after drone strikes
Amazon
May 1, 2026 at 3:23 PM ET
Minnesota bans fake AI nudes; app makers face $500K
Minnesota
May 1, 2026 at 3:23 PM ET
Page 21439 of 21439
Same format. Every time.
Continue reading — sign in or create a free account with
